Universal (UVV) Q1 2025 earnings summary

Executive summary

• Revenue for Q1 FY2025 was $597.1 million, up 15% year-over-year, with both Tobacco and Ingredients segments contributing to growth.

• Operating income increased 56% to $17.2 million, driven by higher sales volumes and prices, especially in tobacco.

• Net income was $0.1 million ($0.01 per diluted share), reversing a net loss of $2.1 million in the prior year quarter.

• Strong demand in tobacco and improved performance in ingredients, especially from new product sales, drove results; Lancaster, PA expansion on track for H2 FY2025.

• Debt levels remain elevated due to working capital needs and early crop purchasing, but 87% of tobacco inventory is committed and working capital is expected to unwind during FY2025.

Financial highlights

• Consolidated sales increased by $79.3 million year-over-year, mainly from higher tobacco prices and volumes and increased Ingredients sales.

• Gross profit margin was 16.1%, down 60 bps from the prior year quarter due to higher cost of goods sold.

• Operating income rose by $6.2 million to $17.2 million; diluted EPS improved by $0.09 to $0.01.

• Selling, general, and administrative expenses rose by $3.2 million, mainly due to unfavorable foreign currency comparisons.

• Interest expense rose by $5.2 million due to higher rates and debt balances.

Outlook and guidance

• Tobacco shipment timing and revenue recognition expected to be more weighted to the second half of FY2025.

• Elevated green tobacco prices are expected to incentivize increased planting, potentially balancing the market in coming years.

• Cost savings from European sheet production consolidation expected to flow through in FY2026.

• SG&A expected to come in below $311 million for FY2025.

• Interest expense anticipated to decrease as inventory is shipped and leverage unwinds in the second half.